Woojung BIO

Woojung BIO provides laboratory testing services used to assess the safety and quality of pharmaceuticals, medical devices, and related products, including tests that check for genetic toxicity, bacterial contamination, and sterilisation effectiveness.

Its clients are broadly companies and researchers in the life-sciences and pharmaceutical industries that need independent, regulated testing before products can be approved. The company is listed on KOSDAQ, South Korea's technology and small-cap stock exchange. Its service portfolio spans both cell-based (in-vitro) and live-organism (in-vivo) testing methods, as well as specialised techniques such as surface plasmon resonance screening used in early-stage drug discovery.